AlbionVC

There are some mega-trends playing out across developed-world workforces that startups are picking up on. There’s the digitization of healthcare, the “platforming” of employee services a

Financial institutions have struggled to develop their own technologies, hence the rise of neo-banks which used Open Banking regulations to build their own fintech stacks. That has led to a wave of in

In recent years, there’s been an explosion in the usage of APIs — the interfaces that software apps use to communicate with each other. When asked to predict API usage in 2022 in a recent

Millions around the world suffer strokes every year, and millions more are in recovery from one they’ve suffered. Regaining the use of affected limbs and capabilities is a long road, but one tha

Consumer packaged goods companies — think PepsiCo or Nabisco — face steep challenges from the rising cost of living and distribution. As inflation continues unabated, consumers’ disp

Relocating employees can involve up to 20-30 different complex processes, while many of the support packages on the market can be inflexible and expensive. Plus, relocating services are usually only a

You might well have a sleep app that tracks your sleep. I use Sleep Cycle, and have found it has started to even tell me when I cough during the night. It turns out you can run machine learning over h

Panaseer, which takes a data science approach to cybersecurity, has raised $26.5 million in a Series B funding led by AllegisCyber Capital. Existing investors, including Evolution Equity Partners, Not

WeGift, the London-based startup that has built an “incentive marketing” platform that lets businesses easily issue e-gift cards and other digital rewards to customers, has raised $8 milli

Seldon is a U.K. startup that specializes in the rarified world of development tools to optimize machine learning. What does this mean? Well, dear reader, it means that the “AI” that companies are

Medtech startup uMotif has an app that allows patients to monitor themselves for treatments or drug trials, which then feeds into a platform, allowing a much faster approach to clinical studies. It ha